Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Government Programs

Five Healthcare Predictions

2020 was a transformative year. Here's what might happen next with COVID-19, pharmacy cost, telehealth, and more.

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman

With bid season approaching, payers' pharmacy teams must re-evaluate how to competitively position themselves for success.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Future Truths: Inevitable and Inspiring

Harnessing genomics will transform our daily lives, disrupt payer, provider, and pharma business models, and create new markets for next-generation prevention.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman

Hard-hitting yet human-centered consumer communications will ensure more patients don't delay necessary medical care.

Chief Marketing and Communications Officer, Memorial Sloan Kettering
Senior Partner, Lippincott
Partner, Health and Life Sciences, Oliver Wyman

Summary of CY2022 Advance Notice Summary Part II

CMS proposes Stars rating changes, revises MA plan definitions, calls for new COVID-19 vaccination measures, and more.

Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman

Insights in your inbox

Subscribe

Returning to work, school, and daily life in a recovering economy means co-existing with COVID-19.

Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner and Co-Lead of Digital Transformation, EMEA, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

COVID-19 is here to stay. In the meantime, hospitals' roles are greatly expanding.

Partner and CMO, Health and Life Sciences, Oliver Wyman

Nadja West joins our podcast to discuss her experience leading soldiers through a health crisis with trust and empathy.

US Army Lieutenant General (Retired)
Partner, Health and Life Sciences, Oliver Wyman

Chinese platforms and service providers are experiencing a spike in tech adoption and utilization amidst the pandemic.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Part 2: Healthcare’s ‘Corona Effect’

Ten expectations regarding voluntary offerings, telemedicine, direct contracting, and more as COVID-19 unfolds.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe